In addition, resistin facilitates breast cancer progression via TLR4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)/signal transducer and activator of transcription 3 (STAT3) signaling pathway-mediated induction of mesenchymal phenotypes and stemness properties [31]. Here, NFKB1 is linked to breast cancer.